Both mRNA expression and CNV of COMMD6 were highest in acute myelocytic leukaemia (AML), meningioma, colorectal cancer and diffuse large B-cell lymphoma (DLBCL) cell lines (Fig. S2A, B). This evidence concerns the gene COMMD6 and acute myeloid leukemia.